Pro-inflammatory biomakers in depression: Treatment with venlafaxine

References

• Aiken L, West S. Multiple regression: testing and interpreting interactions. Sage, Newbury Park, CA 1991
   Google Scholar
• Anda R, Williamson D, Jones D, Macera C, Eaker E, Glassman A, et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 1993; 4: 285–294
   PubMed Web of Science ®Google Scholar
• André P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 2002; 106: 896–899
   PubMed Web of Science ®Google Scholar
• Basterzi AD, Aydemir C, Kisa C, Aksaray S, Tuzer V, Yazici K, et al. IL-6 levels decrease with SSRI treatment in patients with major depression. Hum Psychopharmacol 2005; 20: 473–476
   PubMed Web of Science ®Google Scholar
• Berk M, Wadee AA, Kuschke RH, O'Neill-Kerr A. Acute phase proteins in major depression. J Psychosom Res 1997; 43: 529–534
   PubMed Web of Science ®Google Scholar
• Biasucci, LM, CDC, AHA. 2004. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation, 110:e560–567.
   PubMed Web of Science ®Google Scholar
• Broadley AJ, Korszun A, Jones CJ, Frenneaux MP. Arterial endothelial function is impaired in treated depression. Heart 2002; 88: 521–523
   PubMed Web of Science ®Google Scholar
• Buchanan RD. The development of the Minnesota Multiphasic Personality Inventory. J Hist Behav Sci 1994; 30: 148–161
   Google Scholar
• Capuron L, Hauser P, Hinze-Selch D, Miller AH, Neveu PJ. Treatment of cytokine-induced depression. Brain Behav Immun 2002; 16: 575–580
   PubMed Web of Science ®Google Scholar
• Cohen J, Cohen P. Applied multiple regression/correlation analysis for the behavioral sciences. Lawrence Erlbaum, Hillsdale, NJ 1975
   Google Scholar
• Connor TJ, Leonard BE. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 1998; 62: 583–606
   PubMed Web of Science ®Google Scholar
• Danner M, Kasl SV, Abramson JL, Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom Med 2003; 65: 347–356
   PubMed Web of Science ®Google Scholar
• Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann NY Acad Sci 2001; 933: 222–234
   PubMed Web of Science ®Google Scholar
• De Lorenzo A, Del Gobbo V, Premrov MG, Bigioni M, Galvano F, Di Renzo L. Normal-weight obese syndrome: early inflammation?. Am J Clin Nutr 2007; 85: 40–45
   PubMed Web of Science ®Google Scholar
• Déchanet J, Grosset C, Taupin JL, Merville P, Banchereau J, Ripoche J, et al. CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells. J Immunol 1997; 159: 5640–5647
   Google Scholar
• Di Iorio A, Ferrucci L, Sparvieri E, Cherubini A, Volpato S, Corsi A, et al. Serum IL-1beta levels in health and disease: a population-based study.'The InCHIANTI study'. Cytokine 2003; 22: 198–205
   PubMed Web of Science ®Google Scholar
• Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, et al. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2005; 111: 2299–2305
   PubMedGoogle Scholar
• Hamilton M. Development of a rating scale for primary depression. Br J Social Clin Psychol 1967; 6: 278–296
   PubMed Web of Science ®Google Scholar
• Hicks DR, Wolaniuk D, Russell A, Cavanaugh N, Kraml M. A high-performance liquid chromatographic method for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in biological fluids. Ther Drug Monit 1994; 16: 100–107
   PubMed Web of Science ®Google Scholar
• Himmerich H, Binder EB, Künzel HE, Schuld A, Lucae S, Uhr M, et al. Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis. Biol Psychiatry 2006; 60: 882–888
   PubMed Web of Science ®Google Scholar
• Inoue T, Kato T, Uchida T, Sakuma M, Nakajima A, Shibazaki M, et al. Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting. J Am Coll Cardiol 2005; 46: 239–245
   PubMedGoogle Scholar
• Kamphuis MH, Kalmijn S, Tijhuis MA, Geerlings MI, Giampaoli S, Nissinen A, et al. Depressive symptoms as risk factor of cardiovascular mortality in older European men: the Finland, Italy and Netherlands Elderly (FINE) study. Eur J Cardiovasc Prev Rehabil 2006; 13: 199–206
   PubMedGoogle Scholar
• Kenis G, Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol 2002; 5: 401–412
   PubMed Web of Science ®Google Scholar
• Kubera M, Kenis G, Bosmans E, Kajta M, Basta-Kaim A, Scharpe S, et al. Stimulatory effect of antidepressants on the production of IL-6. Int Immunopharmacol 2004; 4: 185–192
   PubMed Web of Science ®Google Scholar
• Kubera M, Lin AH, Kenis G, Bosmans E, van Bockstaele D, Maes M. Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J Clin Psychopharmacol 2001; 21: 199–206
   PubMed Web of Science ®Google Scholar
• Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000; 22: 370–379
   PubMed Web of Science ®Google Scholar
• Lee KM, Kim YK. The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder. Int Immunopharmacol 2006; 6: 1298–1304
   PubMed Web of Science ®Google Scholar
• Leo R, Di Lorenzo G, Tesauro M, Razzini C, Forleo GB, Chiricolo G, et al. Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. J Clin Psychiatry 2006; 67: 1760–1766
   PubMed Web of Science ®Google Scholar
• Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004; 66: 305–315
   PubMed Web of Science ®Google Scholar
• Lim HS, Blann AD, Lip GY. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention. Circulation 2004; 109: 2524–2528
   PubMed Web of Science ®Google Scholar
• Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 1995; 19: 11–38
   PubMed Web of Science ®Google Scholar
• Maes M. Introduction to the special section. Int J Neuropsychopharmacol 2002; 5: 329–331
   PubMedGoogle Scholar
• Maes M, Bosmans E, Suy E, Vandervorst C, DeJonckheere C, Raus J. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatr Scand 1991; 84: 379–386
   PubMedGoogle Scholar
• Marques-Deak AH, Neto FL, Dominguez WV, Solis AC, Kurcgant D, Sato F, et al. Cytokine profiles in women with different subtypes of major depressive disorder. J Psychiatr Res 2007; 41: 152–159
   PubMed Web of Science ®Google Scholar
• Mayer B, Holmer SR, Hengstenberg C, Lieb W, Pfeifer M, Schunkert H. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels. Int J Cardiol 2005; 103: 182–186
   PubMed Web of Science ®Google Scholar
• Müller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Müller B, et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 2006; 11: 680–684
   PubMed Web of Science ®Google Scholar
• Myint A-M, Leonard BE, Steinbush HWM, Kim Y-K. Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Dis 2005; 88: 167–173
   PubMed Web of Science ®Google Scholar
• Palazzolo DL, Quadri SK. Interleukin-1 inhibits serotonin release from the hypothalamus in vitro. Life Sci 1992; 51: 1797–1802
   Google Scholar
• Pawlak K, Pawlak D, Mysliwiec M. Inflammation but not oxidative stress is associated with beta-chemokine levels and prevalence of cardiovascular disease in uraemic patients. Cytokine 2006; 35: 258–262
   Google Scholar
• Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation 1996; 94: 3123–3129
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Wykretowicz A, Heymann-Szlachcinska A, Wysocki H. Impairment of endothelial function in unipolar and bipolar depression. Biol Psychiatry 2006; 60: 889–891
   PubMed Web of Science ®Google Scholar
• Serebruany VL, Glassman AH, Malinin AI, Sane DC, Finkel MS, Krishnan RR, et al. Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. Blood Coagul Fibrinolysis 2003; 14: 563–567
   PubMed Web of Science ®Google Scholar
• Suarez EC, Krishnan RR, Lewis JG. The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. Psychosom Med 2003; 65: 362–368
   PubMed Web of Science ®Google Scholar
• Tayebjee MH, Lip GY, Tan KT, Patel JV, Hughes EA, MacFadyen RJ. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease. Am J Cardiol 2005; 96: 339–345
   PubMed Web of Science ®Google Scholar
• Thomas AJ, Davis S, Morris C, Jackson E, Harrison R, O'Brien JT. Increase in interleukin-1beta in late-life depression. Am J Psychiatry 2005; 162: 175–177
   PubMed Web of Science ®Google Scholar
• Tucci M, Quatraro C, Frassanito MA, Silvestris F. Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia. J Hypertens 2006; 24: 1307–1318
   Google Scholar
• Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berlin) 2003; 170: 429–433
   PubMed Web of Science ®Google Scholar
• Vollmer-Conna U, Fazou C, Cameron B, Li H, Brennan C, Luck L, et al. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med 2004; 34: 1289–1297
   PubMed Web of Science ®Google Scholar
• Wichers M, Maes M. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol 2002; 5: 375–388
   PubMed Web of Science ®Google Scholar
• Zhu CB, Blakely RD, Hewlett WA. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 2006; 31: 2121–2131
   PubMed Web of Science ®Google Scholar